Protagonist Therapeutics PTGX EV / sales
EV / sales at other companies
Other financials
Where this comes from
Calculated from Protagonist Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Protagonist Therapeutics's ev / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Protagonist Therapeutics's EV / sales?
- Protagonist Therapeutics (PTGX) reported EV / sales of 88.3× in Q1 2026.
- How has Protagonist Therapeutics's EV / sales changed year-over-year?
- Protagonist Therapeutics's EV / sales increased by 546.2% year-over-year, from 13.7× to 88.3×.
- What is the long-term trend for Protagonist Therapeutics's EV / sales?
- Over 4 years (2021 to 2025), Protagonist Therapeutics's EV / sales has grown at a 20.3% compound annual growth rate (CAGR), from 55.4× to 116.1×.
- What does EV / sales mean?
- Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.